home

Biogen CEO sees bonus pay drop on MS, hemophilia trouble

EVENTSfiercepharma2016-04-21 14:28 Read   137

What a difference a year made for Biogen ($BIIB) CEO George Scangos. After reaping a $4 million-plus cash bonus for 2014 performance, Scangos collected $1.2 million for 2015.

GSK pumping out millions more Ellipta inhalers with new U.K. plant

EVENTSfiercepharma2016-04-21 14:16 Read   92

GlaxoSmithKline CEO Andrew Witty is still counting on new respiratory meds to help pull the company out of the financial doldrums, and he has a new inhaler plant in the U.K. to help meet what he says is growing demand.

Roche details hit to Avastin price in Japan

EVENTSfiercepharma2016-04-21 13:39 Read   178

Expected price cuts for reimbursed drugs in Japan this year have riled domestic and foreign firms with exact details sparse until Roche on the first quarter earnings call gave a figure for oncology drug Avastin.

Boehringer Ingelheim returns to growth after US turnaround

EVENTSpmlive2016-04-21 11:25 Read   79

Boehringer Ingelheim made a return to growth last year after sales rose 11% to €14.8bn, largely thanks to a strong showing by its core prescription drug business in the US.

With Sarepta’s fate uncertain, BioMarin CEO Bienaimé weighs the future of their Duchenne drug

EVENTSfiercebiotech2016-04-21 10:51 Read   75

NEW YORK--Come Monday, Sarepta will get a very clear idea of the odds it faces on finally achieving its years-long quest to gain an FDA approval of its Duchenne muscular dystrophy drug eteplirsen.

Roche, Pfizer lead $42M round for Second Genome’s PoC play in the microbiome

EVENTSfiercebiotech2016-04-21 10:46 Read   135

One of the pioneers in microbiome drug research is winding up for a mid-stage clinical drive after nailing a $42.6 million Series B led by the venture arms of Roche ($RHHBY) and Pfizer ($PFE).

Enterome Raises €14.5 Million in Series C Financing Round Nestlé Health Science Invests alongside Existing Investors

EVENTSyahoo2016-04-21 10:26 Read   69

ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announces that it has raised €14.5 million in a Series C financing round.

Medrio and Clinartis Announce New Partnership

EVENTSmarketwired2016-04-21 09:23 Read   58

Medrio, a leading Software as a Service (SaaS) company providing cloud-based data management capabilities to clinical researchers, and Clinartis, a contract research organization (CRO) providing clinical trial services in the United States and Europe, have announced a new partnership under Medrio's Partner Program.

LabCorp Said to Have Held Talks With INC Research Holdings

EVENTSbloomberg2016-04-21 09:15 Read   75

Laboratory Corp. of America Holdings has held talks with INC Research Holdings Inc. about a possible deal, according to people with knowledge of the matter, as it seeks to solidify its position as the biggest diagnostics company in the U.S.

China probes drugmakers over production methods

EVENTSreuters2016-04-20 14:19 Read   71

Three Chinese drugmakers are under investigation for crimes including using counterfeit medicines, the industry watchdog said, as China cracks down on shoddy practices in the world's second-biggest drugs market.

Johnson & Johnson Reports 2016 First-Quarter Results:

EVENTSinvestor.jnj2016-04-20 14:11 Read   73

Sales of $17.5 Billion Increased 0.6% Versus 2015 First Quarter

Intrexon Forms Two New Collaborations with Harvest Intrexon Enterprise Fund

EVENTSprnewswire2016-04-20 14:02 Read   79

ntrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has entered into Exclusive Channel Collaborations (ECC) with two startups backed by the Harvest Intrexon Enterprise Fund, sponsored by Harvest Capital Strategies, LLC.